J&J Innovation taps Texas for its latest biotech startup incubator

Johnson & Johnson ($JNJ) is taking its network of biopharma incubators to Texas in an expansion of its Janssen Labs initiative. To be located at Houston's Texas Medical Center, the incubator hopes to foster as many as 50 local biotech startups. Report

Suggested Articles

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…

Biogen plans to test its SMA drug Spinraza at a higher-than-approved dose as Novartis' rival gene therapy Zolgensma picks up traction.